SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bharat Kalra who started this subject5/2/2001 11:51:46 AM
From: tuck  Read Replies (2) of 1298
 
Whatever one thinks of Jim McCamant's track record, he does have more knowledge of the industry than most of us, and he is independent. So I will read his stuff. Here he notes CEGE is trading at a substantial discount to assets, has no need for dilution, and will be presenting at ASCO.

tfc.com

In contrast, our own Peter Suzman has his reasons for not liking cancer vaccine companies in general (the following post does not directly concern CEGE):

Message 15742029

Thoughts?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News